Trials
Search / Trial NCT05638269

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Launched by ZHUJIANG HOSPITAL · Nov 25, 2022

Trial Information

Current as of February 05, 2025

Recruiting

Keywords

Cardiovascular Disease Exctracoonic Cancer Nervous System Diseases Endocrine Diseases Urological Diseases Microbial Dysbiosis

ClinConnect Summary

This clinical trial is studying the gut microbiota, which is the community of bacteria and other microorganisms living in our intestines, in patients with serious chronic diseases like various types of cancer, heart issues, and kidney diseases. Researchers want to understand how the gut microbiota differs among patients with these conditions and how it might help in creating better diagnostic tools, which are tests that help doctors identify diseases.

To participate in this study, you need to be between 18 and 75 years old and have been diagnosed with one of the specific diseases being studied. You also need to have lived in the same province as the hospital for the last three years and be willing to sign a consent form agreeing to participate. If you join, you can expect to provide some samples and answer questions about your health. It's important to note that some people, such as those who are pregnant or have recently taken certain medications, won't be eligible. This study is currently recruiting participants, so if you or someone you know fits the criteria, it might be a good opportunity to contribute to important health research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. aged 18-75 years;
  • 2. living in the province where the hospital is located in the last three years;
  • 3. with a medical diagnosis of one of the target diseases;
  • 4. willing to provide written informed consent.
  • Exclusion Criteria:
  • 1. female in pregnancy or lactation(unless the subject is pregnant women);
  • 2. with medical diagnoses of other serious illnesses;
  • 3. with a history of bariatric surgery or intestinal resection, except for appendectomy;
  • 4. individual who was treated with drugs in the preceding 1 month, including antibiotics, metformin, statins, acid inhibitor, probiotics, and probiotics; individuals having consumed yogurt more than 3 times in the preceding 1 month; heavy drinkers who have consumed more than 4 taels of liquor or 1000ml of beer; frequent alcohol consumers who have drunk per week in the last month.

Trial Officials

Yan He

Study Chair

Zhujiang Hospital

About Zhujiang Hospital

Zhujiang Hospital, affiliated with the Southern Medical University in Guangzhou, China, is a leading clinical research institution dedicated to advancing medical science and improving patient care through rigorous clinical trials. With a strong commitment to ethical standards and patient safety, the hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals. Its state-of-the-art facilities enable the execution of innovative studies across various therapeutic areas, contributing valuable insights to the global medical community. Zhujiang Hospital aims to foster collaboration with academic institutions, pharmaceutical companies, and regulatory bodies to ensure the successful development of new therapies and enhance treatment options for patients.

Locations

Nanning, Guangxi, China

Fuzhou, Fujian, China

Wuxi, Jiangsu, China

Fuzhou, Fujian, China

Lanzhou, Gansu, China

Lanzhou, Gansu, China

Taiyuan, Shanxi, China

Zhuzhou, Hunan, China

Kunming, Yunnan, China

Guiyang, Guizhou, China

Xiangyang, Hubei, China

Fuzhou, Fujian, China

Ningbo, Zhejiang, China

Nanning, Guangxi, China

Chaoyang, Beijing, China

Nanchuan, Chongqing, China

Yongchuan, Chongqing, China

Foshan, Guangdong, China

Guangzhou, Guangdong, China

Shenzhen, Guangdong, China

Zhongshan, Guangdong, China

Tongliao, Guangxi, China

Guiyang, Guizhou, China

Haikou, Hainan, China

Daqing, Heilongjiang, China

Harbin, Heilongjiang, China

Harbin, Heilongjiang, China

Jixi, Heilongjiang, China

Qiqihar, Heilongjiang, China

Luoyang, Henan, China

Luoyang, Henan, China

Shangqiu, Henan, China

Wuhan, Hubei, China

Xianyang, Hubei, China

Wuzhou, Inner Mongolia Autonomous Region, China

Ji'an, Jiangxi, China

Ganzhou, Jiangx, China

Nanchang, Jiangx, China

Changzhi, Shanxi, China

Taiyuan, Shanxi, China

Xi'an, Shanxi, China

Xi'an, Shanxi, China

Chengdu, Sichuan, China

Guang'an, Sichuan, China

Leshan, Sichuan, China

Beichen, Tianjin, China

Binhai, Tianjin, China

Hexi, Tianjin, China

Kashgar, Xinjiang Uygur Autonomous Region, China

Qujing, Yunnan, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials